Rockland Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$718K Buy
9,177
+202
+2% +$16.3K 0.03% 194
2026
Q1
$778K Buy
8,975
+77
+0.9% +$7.38K 0.03% 174
2025
Q4
$855K Sell
8,898
-5,707
-39% -$554K 0.03% 162
2025
Q3
$1.39M Sell
14,605
-34
-0.2% -$3.13K 0.06% 130
2025
Q2
$1.28M Sell
14,639
-1,445
-9% -$123K 0.06% 109
2025
Q1
$1.45M Buy
16,084
+303
+2% +$27.1K 0.07% 100
2024
Q4
$1.26M Buy
15,781
+504
+3% +$43.6K 0.06% 112
2024
Q3
$1.38M Sell
15,277
-823
-5% -$69.2K 0.07% 110
2024
Q2
$1.27M Sell
16,100
-2,127
-12% -$174K 0.07% 119
2024
Q1
$1.59M Sell
18,227
-2,407
-12% -$205K 0.08% 109
2023
Q4
$1.7M Buy
20,634
+2,139
+12% +$163K 0.09% 109
2023
Q3
$1.45M Buy
18,495
+2,886
+18% +$242K 0.09% 108
2023
Q2
$1.38M Buy
15,609
+126
+0.8% +$10.8K 0.08% 116
2023
Q1
$1.25M Buy
15,483
+335
+2% +$27.3K 0.08% 123
2022
Q4
$1.18M Buy
15,148
+3,560
+31% +$289K 0.07% 138
2022
Q3
$936K Buy
11,588
+2,793
+32% +$251K 0.07% 133
2022
Q2
$789K Sell
8,795
-761
-8% -$77.1K 0.05% 146
2022
Q1
$1.06M Sell
9,556
-453
-5% -$47.9K 0.07% 133
2021
Q4
$1.04M Buy
10,009
+2,218
+28% +$257K 0.07% 147
2021
Q3
$977K Buy
7,791
+214
+3% +$27.7K 0.07% 139
2021
Q2
$941K Buy
7,577
+4,253
+128% +$534K 0.07% 145
2021
Q1
$392K Sell
3,324
-136
-4% -$15.9K 0.03% 207
2020
Q4
$406K Sell
3,460
-782
-18% -$86.1K 0.03% 197
2020
Q3
$441K Sell
4,242
-2,180
-34% -$219K 0.04% 186
2020
Q2
$589K Sell
6,422
-736
-10% -$70.6K 0.05% 163
2020
Q1
$645K Sell
7,158
-2,558
-26% -$272K 0.07% 142
2019
Q4
$1.1M Buy
9,716
+1,824
+23% +$200K 0.09% 133
2019
Q3
$844K Buy
7,892
+1,210
+18% +$126K 0.08% 149
2019
Q2
$651K Buy
+6,682
New +$610K 0.06% 160
2019
Q1
Sell
-4,437
Closed -$404K 240
2018
Q4
$404K Buy
4,437
+2,270
+105% +$212K 0.05% 171
2018
Q3
$213K Buy
+2,167
New +$200K 0.03% 212
2018
Q1
Sell
-2,528
Closed -$204K 215
2017
Q4
$204K Buy
+2,528
New +$202K 0.03% 204
2015
Q2
Sell
-4,840
Closed -$377K 142
2015
Q1
$377K Buy
4,840
+267
+6% +$20.2K 0.08% 106
2014
Q4
$330K Buy
4,573
+128
+3% +$8.89K 0.07% 111
2014
Q3
$275K Buy
4,445
+550
+14% +$35K 0.06% 106
2014
Q2
$248K Sell
3,895
-150
-4% -$9.11K 0.06% 107
2014
Q1
$249K Buy
4,045
+76
+2% +$4.43K 0.06% 108
2013
Q4
$228K Buy
3,969
+72
+2% +$4.08K 0.05% 114
2013
Q3
$208K Hold
3,897
0.06% 108
2013
Q2
$201K Buy
+3,897
New +$193K 0.06% 108

Other funds holding MDT

Rockland Trust's MDT Position: Q2 2026 in Review

Rockland Trust increased its Medtronic (MDT) stake by 2.3% in Q2 2026, buying an estimated $16.3K and bringing the position to 9,177 shares worth $718K. The position accounts for 0.03% of the portfolio, ranked #194.

Rockland Trust first reported a position in MDT in Q2 2013 and has held it in 40 quarters since. The position peaked at $1.7M in Q4 2023. 1,015 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Rockland Trust held 9,177 shares of Medtronic worth $718K as of Q2 2026.
  • Rockland Trust bought 202 Medtronic shares in Q2 2026, an estimated $16.3K.
  • Medtronic made up 0.03% of Rockland Trust's portfolio in Q2 2026, its #194 holding.
  • Rockland Trust first reported a position in Medtronic in Q2 2013 and has held it in 40 quarters since.
  • Rockland Trust's Medtronic position peaked at $1.7M in Q4 2023.
  • 1,015 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.